WAVE3 upregulation in esophageal squamous cell carcinoma and its effect on the migration of human esophageal cancer cell lines in vitro

Li,Xuebing; Geng,Jie; Ren,Zhenzhen; Xiong,Chao; Li,Yuqing; Liu,Hongchun

doi:10.3892/mmr.2020.11126

WAVE3 upregulation in esophageal squamous cell carcinoma and its effect on the migration of human esophageal cancer cell lines in vitro

Authors:
- Xuebing Li
- Jie Geng
- Zhenzhen Ren
- Chao Xiong
- Yuqing Li
- Hongchun Liu
View Affiliations

Affiliations: Department of Medical Laboratory, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China
Published online on: May 5, 2020 https://doi.org/10.3892/mmr.2020.11126
Pages: 465-473
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the role of Wiskott‑Aldrich syndrome verprolin‑homologous protein 3 (WAVE3) in the progression of esophageal squamous cell carcinoma (ESCC), and to explore its effect on the migration of esophageal cancer cell lines in vitro. The expression level of WAVE3 in ESCC tissues was determined via immunohistochemistry, and the relative levels of WAVE3 mRNA and micro (mi)RNA200b were assessed in the serum of patients with ESCC using reverse transcription‑quantitative PCR (RT‑qPCR). Following cell transfection, the levels of miRNA200b and WAVE3 protein were determined via RT‑qPCR and western blot analysis, and cell migration was examined using a Transwell assay. Subsequently, the clinical parameters were used to analyze whether the expression of WAVE3 in tissues and serum was associated with the occurrence and development of ESCC. The results demonstrated that the expression of WAVE3 was increased in ESCC tissues compared with normal tissues. The results also revealed increased expression levels of WAVE3 and decreased expression levels of miRNA200b in the serum of patients with ESCC, compared with healthy volunteers. High expression of WAVE3 was significantly associated with tumor TNM stage, invasion depth and lymphatic invasion of ESCC. In cells transfected with miRNA200b mimic, the miRNA200b was overexpressed, WAVE3 protein was downregulated and cell migration ability was decreased. The results of the present study suggest that WAVE3 may serve as an oncogene in ESCC, and its inhibition via miRNA200b decreased tumor cell migration. Therefore, WAVE3 may serve as a novel biological marker and therapeutic target for ESCC.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Liang H, Fan JH and Qiao YL: Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 14:33–41. 2017. View Article : Google Scholar : PubMed/NCBI
3	Malhotra GK, Yanala U, Ravipati A, Follet M, Vijayakumar M and Are C: Global trends in esophageal cancer. J Surg Oncol. 115:564–579. 2017. View Article : Google Scholar : PubMed/NCBI
4	Arnold M, Soerjomataram I, Ferlay J and Forman D: Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 64:381–387. 2015. View Article : Google Scholar : PubMed/NCBI
5	Chen J, Kwong DL, Cao T, Hu Q, Zhang L, Ming X, Chen J, Fu L and Guan X: Esophageal squamous cell carcinoma (ESCC): Advance in genomics and molecular genetics. Dis Esophagus. 28:84–89. 2015. View Article : Google Scholar : PubMed/NCBI
6	Tsukada Y, Higashi T, Shimada H, Kikuchi Y and Terahara A: The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan. Int J Clin Oncol. 23:81–91. 2018. View Article : Google Scholar : PubMed/NCBI
7	Zhang L, Ma J, Han Y, Liu J, Zhou W, Hong L and Fan D: Targeted therapy in esophageal cancer. Expert Rev Gastroenterol Hepatol. 10:595–604. 2016. View Article : Google Scholar : PubMed/NCBI
8	Katada C, Muto M, Momma K, Arima M, Tajiri H, Kanamaru C, Ooyanagi H, Endo H, Michida T, Hasuike N, et al: Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae-a multicenter retrospective cohort study. Endoscopy. 39:779–783. 2007. View Article : Google Scholar : PubMed/NCBI
9	Lin D, Ma L, Ye T, Pan Y, Shao L, Song Z, Jiang S, Chen H and Xiang J: Results of neoadjuvant therapy followed by esophagectomy for patients with locally advanced thoracic esophageal squamous cell carcinoma. J Thorac Dis. 9:318–326. 2017. View Article : Google Scholar : PubMed/NCBI
10	Fink U, Stein HJ, Bochtler H, Roder JD, Wilke HJ and Siewert JR: Neoadjuvant therapy for squamous cell esophageal carcinoma. Ann Oncol. 5 (Suppl 3):S17–S26. 1994. View Article : Google Scholar : PubMed/NCBI
11	Heise JW, Heep H, Frieling T, Sarbia M, Hartmann KA and Röher HD: Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus. BMC Cancer. 1:202001. View Article : Google Scholar : PubMed/NCBI
12	Xu SY, Liu Z, Ma WJ, Sheyhidin I, Zheng ST and Lu XM: New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma. Biomarkers. 14:340–346. 2009. View Article : Google Scholar : PubMed/NCBI
13	Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM and Hjelm NM: Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis. Am J Hum Genet. 62:768–775. 1998. View Article : Google Scholar : PubMed/NCBI
14	Thrasher AJ and Burns SO: WASP: A key immunological multitasker. Nat Rev Immunol. 10:182–192. 2010. View Article : Google Scholar : PubMed/NCBI
15	Takenawa T and Suetsugu S: The WASP-WAVE protein network: Connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol. 8:37–48. 2007. View Article : Google Scholar : PubMed/NCBI
16	Machesky LM and Insall RH: Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr Biol. 8:1347–1356. 1998. View Article : Google Scholar : PubMed/NCBI
17	Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, Yata J, Mizutani S, Ochs HD and Nonoyama S: Clinical course of patients with WASP gene mutations. Blood. 103:456–464. 2004. View Article : Google Scholar : PubMed/NCBI
18	Miki H, Suetsugu S and Takenawa T: WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J. 17:6932–6941. 1998. View Article : Google Scholar : PubMed/NCBI
19	Sossey-Alaoui K, Ranalli TA, Li X, Bakin AV and Cowell JK: WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res. 308:135–145. 2005. View Article : Google Scholar : PubMed/NCBI
20	Sossey-Alaoui K, Li X, Ranalli TA and Cowell JK: WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of phosphatidylinositol 3-kinase. J Biol Chem. 280:21748–21755. 2005. View Article : Google Scholar : PubMed/NCBI
21	Zhu Z, Chen W, Yin X, Lai J, Wang Q, Liang L, Wang W, Wang A and Zheng C: WAVE3 induces EMT and promotes migration and invasion in intrahepatic cholangiocarcinoma. Dig Dis Sci. 61:1950–1960. 2016. View Article : Google Scholar : PubMed/NCBI
22	Ji Y, Li B, Zhu Z, Guo X, He W, Fan Z and Zhang W: Overexpression of WAVE3 promotes tumor invasiveness and confers an unfavorable prognosis in human hepatocellular carcinoma. Biomed Pharmacother. 69:409–415. 2015. View Article : Google Scholar : PubMed/NCBI
23	Davuluri G, Sossey-Alaoui K and Plow E: Abstract 2702: WAVE3 regulates NF B signaling and sensitizes cancer cells to apoptosis and cell death driven by TNF. Cancer Res. 73 (Suppl 8):27022013.
24	Davuluri G, Augoff K, Schiemann WP, Plow EF and Sossey-Alaoui K: WAVE3-NFκB interplay is essential for the survival and invasion of cancer cells. PLoS One. 9:e1106272014. View Article : Google Scholar : PubMed/NCBI
25	Huang S, Huang C, Chen W, Liu Y, Yin X, Lai J, Liang L, Wang Q, Wang A and Zheng C: WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer. Int J Oncol. 53:672–684. 2018.PubMed/NCBI
26	Jaganathan S, Yue P, Paladino DC, Bogdanovic J, Huo Q and Turkson J: A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells. PLoS One. 6:e196052011. View Article : Google Scholar : PubMed/NCBI
27	Kulkarni S, Augoff K, Rivera L, McCue B, Khoury T, Groman A, Zhang L, Tian L and Sossey-Alaoui K: Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer. PLoS One. 7:e428952012. View Article : Google Scholar : PubMed/NCBI
28	Sossey-Alaoui K, Safina A, Li X, Vaughan MM, Hicks DG, Bakin AV and Cowell JK: Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol. 170:2112–2121. 2007. View Article : Google Scholar : PubMed/NCBI
29	Moazzam M, Ye L, Sun PH, Kynaston H and Jiang WG: Knockdown of WAVE3 impairs HGF induced migration and invasion of prostate cancer cells. Cancer Cell Int. 15:512015. View Article : Google Scholar : PubMed/NCBI
30	Paterson EL, Kazenwadel J, Bert AG, Khew-Goodall Y, Ruszkiewicz A and Goodall GJ: Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. Neoplasia. 15:180–191. 2013. View Article : Google Scholar : PubMed/NCBI
31	Valencia-Sanchez MA, Liu J, Hannon GJ and Parker R: Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
32	Sossey-Alaoui K, Bialkowska K and Plow EF: The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion. J Biol Chem. 284:33019–33029. 2009. View Article : Google Scholar : PubMed/NCBI
33	Honor H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED and Thompson EW: Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol. 213:374–383. 2007. View Article : Google Scholar : PubMed/NCBI
34	Taylor MA, Davuluri G, Parvani JG, Schiemann BJ, Wendt MK, Plow EF, Schiemann WP and Sossey-Alaoui K: Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells. Breast Cancer Res Treat. 142:341–353. 2013. View Article : Google Scholar : PubMed/NCBI
35	Yue Z, Feng W, Xiangke L, Liuxing W, Qingxia F and Jianbo G: WAVE3 promotes epithelial-mesenchymal transition of gastric cancer through upregulation of Snail. Cancer Gene Ther. 21:499–506. 2014. View Article : Google Scholar : PubMed/NCBI
36	Savagner P: Leaving the neighborhood: Molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays. 23:912–923. 2001. View Article : Google Scholar : PubMed/NCBI
37	Chen Y, Sun Y, Chen L, Xu X, Zhang X, Wang B, Min L and Liu W: miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling. Mol Med Rep. 7:1579–1584. 2013. View Article : Google Scholar : PubMed/NCBI
38	Cowherd SM: Tumor staging and grading: A primer. Methods Mol Biol. 823:1–18. 2012. View Article : Google Scholar : PubMed/NCBI
39	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
40	Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell. 27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
41	Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
42	Lu J, Wang SL, Wang YC, Wu YN, Yu X, Zhao WZ and Wang JH: High WAVE3 expression correlates with proliferation, migration and invasion in human ovarian cancer. Oncotarget. 8:41189–41201. 2017. View Article : Google Scholar : PubMed/NCBI
43	Jin H, Xie Q, Guo X, Xu J, Wang A, Li J, Zhu J, Wu XR, Huang H and Huang C: p63α protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion. J Biol Chem. 292:15952–15962. 2017. View Article : Google Scholar : PubMed/NCBI
44	Sossey-Alaoui K, Li X and Cowell JK: c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia formation and cell migration. J Biol Chem. 282:26257–26265. 2007. View Article : Google Scholar : PubMed/NCBI
45	Sossey-Alaoui K: Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis. Semin Cell Dev Biol. 24:287–297. 2013.PubMed/NCBI
46	Fernando HS, Sanders AJ, Kynaston HG and Jiang WG: WAVE3 is associated with invasiveness in prostate cancer cells. Urol Oncol. 28:320–327. 2010. View Article : Google Scholar : PubMed/NCBI
47	Condeelis J and Segall JE: Intravital imaging of cell movement in tumours. Nat Rev Cancer. 3:921–930. 2003. View Article : Google Scholar : PubMed/NCBI
48	Takenawa T and Miki H: WASP and WAVE family proteins: Key molecules for rapid rearrangement of cortical actin filaments and cell movement. J Cell Sci. 114:1801–1809. 2001.PubMed/NCBI